Probing the binding of interleukin-23 to individual receptor components and the IL-23 heteromeric receptor complex in living cells using NanoBRET
Charles S. Lay(University of Nottingham), Stephen J. Hill(University of Nottingham), Angela Bridges(GlaxoSmithKline (United Kingdom)), Peter D. Craggs(GlaxoSmithKline (United Kingdom)), Stephen J. Briddon(University of Nottingham), Joëlle Goulding(University of Nottingham), Zoja Soloviev(GlaxoSmithKline (United Kingdom))
Cited by 13
Related Papers
BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models
|PLoS ONE|2013|205
Agonist and Inverse Agonist Actions of β-Blockers at the Human β2-Adrenoceptor Provide Evidence for Agonist-Directed Signaling
|Molecular Pharmacology|2003|187
The p85 Subunit of Phosphatidylinositol 3-Kinase Associates with the Fc Receptor γ-Chain and Linker for Activitor of T Cells (LAT) in Platelets Stimulated by Collagen and Convulxin
|Journal of Biological Chemistry|1998|145
Evolution of β-blockers: from anti-anginal drugs to ligand-directed signalling
|Trends in Pharmacological Sciences|2011|134
Quantitative analysis of the formation and diffusion of A <sub>1</sub> -adenosine receptor-antagonist complexes in single living cells
|Proceedings of the National Academy of Sciences|2004|117